The global Anatomic Pathology Market in terms of revenue was estimated to be worth $35.1 billion in 2021 and is poised to reach $49.1 billion by 2026, growing at a CAGR of 7.0% from 2021 to 2026. Growing demand for personalized medicines and increasing number of cancer and infectious disease cases are the key drivers of the market, according to a report by MarketsandMarkets.
Anatomic pathology is a medical specialty that deals with the diagnosis, classification, and interpretation of diseases and abnormalities through the examination of tissues, organs, and bodily fluid. It is a crucial part of the diagnosis and treatment of various diseases, including cancer. The medical field is rapidly advancing with the development of advanced technology, such as digital pathology and image analysis. This, in turn, is expected to boost the anatomic pathology market during the forecast period.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=137323145
Moreover, the increasing adoption of personalized medicines and other treatments, such as gene therapy, is fueling the growth of the market. The increase in the number of cancer cases has also propelled the demand for anatomic pathology tests, thereby contributing to the market growth.
Furthermore, the increasing demand for tissue-based diagnosis, especially in the diagnosis and treatment of cancer, is also expected to drive the market. This is due to the accuracy and reliability of these tests, which allow for early and accurate diagnosis. Moreover, the increasing awareness about the importance of anatomic pathology tests, especially in the diagnosis of cancer and other diseases, is expected to propel the market.
The market is segmented on the basis of product services, application, end user, and geography. By product services, the market is divided into reagents kits, instruments, and software services. Among these, the reagents kits segment is expected to hold the largest share of the market during the forecast period. This is due to the increasing availability of different types of reagents, such as antibodies and stains, used in anatomic pathology.
The increasing demand for anatomic pathology tests in the diagnosis and treatment of cancer is expected to drive the segment. Furthermore, the rising demand for instruments, such as automated slide staining and tissue microarray systems, is also expected to boost the segment.
The increasing awareness about the importance of anatomic pathology tests, especially in the diagnosis and treatment of cancer, is expected to propel the market. Furthermore, the availability of advanced technology, such as digital pathology and image analysis, is expected to boost the market.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=137323145
Key Market Players
The major players in the anatomic pathology market are F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), and PHC Holdings Corporation (Japan).
This research report categorizes the anatomic pathology market into the following segments and subsegments:
By Product and Service
- Services
- Consumables
- Instruments
By Application
- Disease Diagnostics
- Medical Research
By End User
- Hospital Laboratories
- Clinical Laboratories
- Other End Users
By Region
- North America
- Europe
- Asia Pacific
- Rest of the World
Recent Developments:
- Hologic received premarket approval (PMA) from the FDA for its ThinPrep GenesisTM processor for cytology processing and specimen transfer for downstream applications.
- PHC Holding Corporation completed the acquisition of Thermo Fisher Scientific’s Anatomical Pathology business to strengthen its position in the diagnostics segment.
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=137323145
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: [email protected]
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/anatomic-pathology-market.asp
Visit Our Web Site: https://www.marketsandmarkets.com
Content Source: https://www.marketsandmarkets.com/PressReleases/anatomic-pathology.asp
